1996
DOI: 10.1136/gut.39.4.574
|View full text |Cite
|
Sign up to set email alerts
|

Cost effectiveness of detecting Barrett's cancer.

Abstract: Background-Screening Barrett's oesophagus is controversial owing to a large variation in the reported incidence ofneoplastic change and lack of evidence that screening improves tumour prognosis. Conclusions-The cost of screening for Barrett's cancer is high but may be justified on the basis of the high incidence of detecting early stage disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
64
0
5

Year Published

1999
1999
2010
2010

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 140 publications
(75 citation statements)
references
References 34 publications
6
64
0
5
Order By: Relevance
“…Although the brush biopsy capsule is inexpensive, the hidden costs including preparation of slides and expert cytopathological assessment are considerable. Moreover, despite the alarming increase in the incidence of AdCa of the oesophagus in North America and Europe, screening for neoplasia in Barrett's oesophagus is controversial partly due to the invasive nature and expense of introducing endoscopic biopsy surveillance programmes (Wright et al, 1996).…”
Section: Discussionmentioning
confidence: 99%
“…Although the brush biopsy capsule is inexpensive, the hidden costs including preparation of slides and expert cytopathological assessment are considerable. Moreover, despite the alarming increase in the incidence of AdCa of the oesophagus in North America and Europe, screening for neoplasia in Barrett's oesophagus is controversial partly due to the invasive nature and expense of introducing endoscopic biopsy surveillance programmes (Wright et al, 1996).…”
Section: Discussionmentioning
confidence: 99%
“…Several retrospective studies clearly suggest that patients with Barrett's esophagus in whom adenocarcinoma was detected in a surveillance program have their cancers detected at an earlier stage with resulting dramatically improved 5-year survival compared to similar patients not undergoing rou- [72][73][74][75]. Furthermore, nodal involvement is far less likely in surveyed patients compared to nonsurveyed patients [73,74]. Since esophageal cancer survival is stage-dependent, these studies suggest that survival may be enhanced by endoscopic suveillance.…”
Section: What About Surveillance?mentioning
confidence: 99%
“…Regular surveillance is expensive, and at least the cost-effectiveness of the approach has been questioned. 3 The fact that about 10-20 esophageal biopsies may be needed during a single procedure, concerns about procedure time, cost and safety, may hinder widespread implementation of such surveillance programs.Induction of regression of Barrett's esophagus, especially the endoscopic ablative measures, has generated a lot of interest. In younger age patients, it may be an attractive method both to reduce the risk of malignancy and the cost of surveillance, but this still needs more proof.…”
mentioning
confidence: 99%
“…Regular surveillance is expensive, and at least the cost-effectiveness of the approach has been questioned. 3 The fact that about 10-20 esophageal biopsies may be needed during a single procedure, concerns about procedure time, cost and safety, may hinder widespread implementation of such surveillance programs.…”
mentioning
confidence: 99%
See 1 more Smart Citation